Stay updated with breaking news from Chiara Cremolini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, ON (PRWEB) June 09, 2022 -- Immunotherapy has emerged as the most promising cancer treatment in the last decade with a major impact in oncology by
Combination of modified FOLFOXIRI/panitumumab also caused greater toxicity, study showed
However, in the Phase III PARADIGM trial, there was no difference in survival between the two arms when researchers focused only on patients with right-sided tumors.
(2022-05-26 | NDAQ:OCX) Oncocyte Presents DetermaIO(TM) Data at ASCO 2022 Supporting the Test's Potential to Expand the Clinical Use of Immunotherapy
Gruppo Oncologico del Nord Ovest, a Leading European Clinical Trials Group, Conducts Independent Investigator-Sponsored Clinical Trials for Pharmaceutical...